Fabry's disease medical therapy: Difference between revisions
Jump to navigation
Jump to search
Ghsanadgol (talk | contribs) |
Ghsanadgol (talk | contribs) |
||
Line 7: | Line 7: | ||
==Medical Therapy== | ==Medical Therapy== | ||
=== Specific Treatment === | ===Specific Treatment=== | ||
* Enzyme: alpha-galactosidase A enzyme | *Enzyme: alpha-galactosidase A enzyme | ||
** Enzyme replacement therapy: recombinant human | **Enzyme replacement therapy: recombinant human enzymes | ||
*** Agalsidase alfa( Replagal) | ***Agalsidase alfa( Replagal) | ||
*** Agalsidase beta (Fabrazyme) | ***Agalsidase beta (Fabrazyme) | ||
** Increase the enzyme activity if GLA gene positive: Migalastat | **Increase the enzyme activity if GLA gene positive: Migalastat | ||
** | ** | ||
==References== | ==References== |
Revision as of 14:30, 15 April 2022
Fabry's disease Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Fabry's disease medical therapy On the Web |
American Roentgen Ray Society Images of Fabry's disease medical therapy |
Risk calculators and risk factors for Fabry's disease medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Medical Therapy
Specific Treatment
- Enzyme: alpha-galactosidase A enzyme
- Enzyme replacement therapy: recombinant human enzymes
- Agalsidase alfa( Replagal)
- Agalsidase beta (Fabrazyme)
- Increase the enzyme activity if GLA gene positive: Migalastat
- Enzyme replacement therapy: recombinant human enzymes